|
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, sex, gender, weight, race, and ethnicity were not provided.Section e.1: the initial reporter phone: (b)(6).Section h.3: the device is available to be returned for evaluation and testing.However, it has not been received to date.If the device returns, a device investigation will be performed.Lake region medical performed a review of the device history records relative to the manufacturing, inspection, and packaging of the lot: 9751064.The history record indicates this product was final inspection tested at lake region medical and was determined to be acceptable.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
It was reported that the 4.0mm dia x 23mm enterprise®2 (enf402312 / 10021142) was prematurely deployed at the hub and slipped out.There was no report of any negative patient impact.On 12-may-2026, additional information was received indicating that the stent was prematurely detached and was no longer on the delivery wire.The information confirmed there was no adverse outcome to the patient.Based on the additional information received on 12-may-2026, the event has been determined to be usfda reportable under 21 cfr 803 with a classification of ¿malfunction.¿.
|